----item----
version: 1
id: {F60D168B-7E91-401D-B775-26ACC73EFA99}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/07/22/PharmAsia News business bulletin
parent: {D254BC4D-71AA-4496-91EB-0FC2A9B440F2}
name: PharmAsia News business bulletin
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 1a3928df-fd7d-4946-b9f3-bfe3f5f98b0f

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{F5161CC2-772F-472E-A21C-BF196343462E}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 32

PharmAsia News business bulletin
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 32

PharmAsia News business bulletin
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 4161

<p>A new regular roundup of commercial stories appearing in <i>Scrip</i>&rsquo;s sister publication <i>PharmAsia News</i>, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. </p><p><p>Full stories can be accessed by clicking on the story title (subscription required). </p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/23/bayer-eyes-new-areas-for-collaborative-singapore-research" target="_new">Bayer Eyes New Areas For Collaborative Singapore Research</a></p><p>Bayer HealthCare is expanding its spread of research collaborations in Singapore into new therapeutic areas, tapping local academic and other institutions to assist with drug and biomarker development and commercialization.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/23/interview-hilleman-seeks-hib-partners-as-it-hones-focus" target="_new">INTERVIEW: Hilleman Seeks Hib Partners As It Hones Focus</a></p><p>Indian vaccine R&D firm Hilleman Laboratories says it's talking to potential partners about the clinical testing of a new "breakthrough" vaccine formulation that could create a far cheaper, more effective way to combat Haemophilus influenzae type b (Hib) and be in production in the next three to four years.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/22/why-no-blockbusters-from-korea" target="_new">Why No Blockbusters from Korea?</a></p><p>During a recent seminar in Seoul, South Korean pharma experts discussed problems related to the country's drug pricing system, the current status of the domestic pharma industry and ways to boost R&D. Participants called for the need for fundamental changes to the pricing system to make it more friendly to companies and provide better incentives to develop innovative drugs.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/22/foreign-industry-unites-against-annual-japan-price-cuts" target="_new">Foreign Industry Unites Against Annual Japan Price Cuts</a></p><p>Major groups representing the foreign innovation-based pharma and medtech industries in Japan have come out in strong united opposition to a proposal to adopt annual, rather than biennial, reimbursement price cuts, warning this could adversely affect investment and the provision of healthcare.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/21/korean-pharma-asks-for-govt-support-as-mers-hits-sales" target="_new">Korean Pharma Asks For Govt Support as MERS Hits Sales</a></p><p>South Korean pharma firms have decided to ask the government to support the industry, which is suffering from sales decline due to the recent outbreak of the Middle East Respiratory Syndrome (MERS) coronavirus. They will ask the government to postpone a planned drug price cut by one year in an effort to overcome the MERS impact and proceed with drug development and globalization programs.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/21/turkey-company-roundup-abdi-ibrahim-biotech-plant-cuba-project" target="_new">Turkey Company Roundup: Abdi Ibrahim Biotech Plant, Cuba Project</a></p><p>Abdi Ibrahim is to establish Turkey&rsquo;s biggest biotech drug production facility, while the Ukrainian firm Biofarma will also invest in the country. Meanwhile, Hasbiotech is starting a joint project with the Cuban government for a hepatitis C vaccine facility, and Sanofi has made personnel changes.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/17/shifting-china-otc-sales-affect-jampj-prompt-new-alliances" target="_new">Shifting China OTC Sales Affect J&J, Prompt New Alliances</a></p><p>Johnson & Johnson sees shifting consumer behavior in China as a reason for its slowing OTC sales in this market, a trend that could potentially force more multinationals to embrace the e-commerce phenomenon. Pfizer is among the first such companies to form a tie-up with a domestic firm to surf the surging online drug sales tide.</p><p><p>www.pharmasianews.com</p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 250

<p>A new regular roundup of commercial stories appearing in <i>Scrip</i>&rsquo;s sister publication <i>PharmAsia News</i>, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 32

PharmAsia News business bulletin
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150722T202556
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150722T202556
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150722T202556
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029362
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 32

PharmAsia News business bulletin
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{DB39CCA6-EB88-422C-8247-AB4AD01491E2}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 13

Headline News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

359575
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042428Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

1a3928df-fd7d-4946-b9f3-bfe3f5f98b0f
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042428Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
